To evaluate the efficacy and safety of rituximab (RTX) in patients with systemic lupus erythematosus (SLE) refractory to standard therapy in the clinical practice setting.
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry
IACCARINO, LUCA;GATTO, MARIELE;ZEN, MARGHERITA;DORIA, ANDREA
2015
Abstract
To evaluate the efficacy and safety of rituximab (RTX) in patients with systemic lupus erythematosus (SLE) refractory to standard therapy in the clinical practice setting.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
article.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Accesso gratuito
Dimensione
602.07 kB
Formato
Adobe PDF
|
602.07 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
